Pirentsepin

Roman name

Pirenzepin

Of drugs

Pirentsepin a representative of a new subgroup antiholinergicakih substances -specificakih blocking M -holinoretseptorv. In contrast to the "typical" blocking M-holinoretseptorov (atropine, etc.) pirentsepin selectively inhibits secretion of stomach disorders hydrochloric acid and pepsinoguena (predecessor pepsina-enzyme proteins off), without significant foreclosure effect M-holinoretseptora salivary glands, heart, smooth muscle eyes and other organs.

Storage conditions

List B. In the dark spot.

Indications for use

Applied for the treatment of ostrgh and chronic ulceration of stomach and duodenal ulcer, gastritis high acidity gastric juice began losses gastrointestinal tract associated with the steroid противовоспалительны х funds (acetylsalicylic acid, sodium musk, metilsalicilat, etc.).

Dosing and Administration

Assign inwards and parenteral (bypassing the digestive tract). Inside of 0.05 g (50 mg) in the morning and evening for 30 minutes to write admission; Combination with a small amount of water. The course of treatment of at least 4 weeks. (4-8 weeks). without a break. When a fast subjective (not confirmed a medical examination), the improvement should continue receiving drug because of the possible degradation.

Side-Effects

Moved pirentsepin usually well. Sometimes a dry mouth, light of the passing of view. The blood-brain barrier (the barrier between the blood and brain tissue) product is not making inroads central holinoliticski action is not.

Contraindications

The drug should not be used in the first 3 months. pregnancy.

Form of

Answers to 25 and 50 mg in a package of 50 and 100 pieces; Ml to 2 ml containing 10 mg dry product with its solvent, in a package of 5 pieces.

Directory → Wegetotropona funds → Holinoliticaskie funds → M-holinolitiki → Pirentsepin